Skip to content

S 4194 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
S 4194

New Jersey · 222 session · senate

S 4194Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Status: In committee
Latest action: 2026-06-30 — Substituted by A4852 (ACS)
Primary sponsor: Vitale, Joseph F.

Substituted by another Bill

Track this bill View changes+2188 / −240 words · Large

Sponsors

Vitale, Joseph F. · primaryprimary
Gopal, Vin (Democratic) · primaryprimary

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

Mukherji, Raj (Democratic) · primaryprimary

Versions

IntroducedMay 11, 2026
Statement—
Senate Committee Substitute—

Legislative history

Jun 30, 2026
Substituted by A4852 (ACS)
Jun 11, 2026
Reported from Senate Committee as a Substitute, 2nd Reading
May 11, 2026
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Official sources

Version 0PDF HTML
Version 1PDF HTML
Version 2PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for S 4194. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track S 4194, get alerts, annotate diffs, and export Word work product.